Navigation Links
Bayer Voluntarily Withdraws BAYCOL - A Drug Associated With 50 Deaths,,

Baycol is a prescription drug manufactured by Bayer Pharmaceuticals. Baycol, which was initially approved by the FDA, belongs to a statin group of drugs that lowers cholesterol by blocking enzymes that are essential in the synthesis of cholesterol in the body.

Bayer Pharmaceuticals has voluntarily recalled its cholesterol drug Baycol( cerivastatin ) because // it has been linked to approximately 50 deaths. Baycol can cause a muscular side effect called rhabdomyolysis – destroyed muscles cells are released into the bloodstream and cause severe muscle pain, fever, weakness and vomiting. This condition can also lead to kidney failure.

The FDA said fatal reports with Baycol had been reported most frequently when the drug was used at higher doses, in elderly patients, and especially when taken in combination with another cholesterol-lowering drug called gemfibrozil. It said patients taking Baycol should consult their physicians about switching to another medication to control their cholesterol agents. Pharmacies will be instructed to return the product to the manufacturer for a refund.

FDA announced that Bayer Pharmaceutical Division is voluntarily withdrawing Baycol from the U.S. market. Patients who are taking Baycol should discontinue Baycol and consult their physicians about switching to alternate medications to control their cholesterol levels.


'"/>




Page: 1

Related medicine news :

1. Bayer Wins Positive Response For Marketing Its Cancer Drug
2. Genomatix Licensed By Bayer Healthcare
3. Bayer to Market Biocon Insulin in China
4. Test for Esophageal Reflux Licensed to Bayer by University
5. Hospital Withdraws McDonalds Reward Scheme
6. Moderate Use of Analgesics - Not Associated With Kidney Dysfunction
7. Associated therapy for multiple myeloma
8. Associated scan for detecting ovarian cancer spread
9. Ginseng Associated with Pregnancy Risks
10. Enzyme Associated with Memory
11. 3 die, 500 sickened in nations largest hepatitis A outbreak Associated Press

Post Your Comments:
(Date:11/9/2009)..., MAYWOOD, Il. -- Gifted young athletes are und... round. , But a new Loyola University Health Sys...hat such specialization increases the risk of inju...ed States Tennis Association junior competition fo...re more likely to withdraw from tournaments for me...
(Date:11/8/2009)..., WASHINGTON, Nov. 8 ...ssued the following statement about the passage of...s and the American voters a lot about core values....core values, seeking to overcome the struggles ord...gles mean that many cannot afford basic healthcare...
(Date:11/8/2009)...traight-back, chest-out position promotes self-ass...8 (HealthDay News) -- Your mother may have been ri...arch suggests that good posture could make you fee...of us were taught that sitting up straight gives a...co-author of the study and a psychology professor ...
(Date:11/8/2009)..., WASHINGTON, Nov. 8 ...a press conference following the House passage of ...Act. The bill passed by a vote of 220 to 215. Be...nd some of my colleagues just received a call from... congratulating us on a great victory for the Amer...
(Date:11/8/2009)... Freeze-drying of biopharm...Mississauga, Ontario facility. , ...homas Wellner, President and CEO of Therapure Biop...ken delivery of a commercial scale pharmaceutical ...scale freeze drying (lyophilization) available for...
Breaking Medicine News(10 mins):Health News:Young tennis players who play only 1 sport are more prone to injuries 2Health News:Catholics for Choice Statement on Healthcare Reform Bill 2Health News:Good Posture May Inspire Confidence 2Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2
...ally common after the death of a spouse , ... keep up active social lives as they age may be do...ng socially active may increase feelings of self-w...llenges, keeping the brain more agile. , "We asses...
...sing Home Care Slashed,$3.7 Million in Year Ahead;...o Publicly Oppose Cuts to Seniors, Medicare Fundin...ck in Minnesota this week for the Memorial Day dis...nistration,s,planned regulatory cuts to seniors, M...
... not like,re-engineering -- they focus on incremen...hese increments can grow to be quite large --,comp...n savings of $1.2,million from their largest-impac...www3.best-in-class.com/dr308.htm ., Quality leade...
...ance to Workers, ERIE, Pa., May 29 Governor Edwa...d adults in Erie County -- many of whom,who work f...a waiting list,to receive health care coverage -- ...ce would also,benefit from the plan,s $42 million ...
...dvanced fibrosis have twice the risk of developing...ndings are published in the June issue of Hepatolo...half of the American Association for the Study of ...hat diabetes increases ones risk for hepatocellula...
...s -, MISSISSAUGA, ON, May 29 /PRNewswire-FirstCal...g development company focused on the research and,...ugh the skin using its,topical and transdermal dru...vel topical pain formulation with the,potential to...
Other Medicine News:Health News:Active Social Life Helps Keep Aging Mind Sharp 2Health News:Active Social Life Helps Keep Aging Mind Sharp 3Health News:Minnesota, National Long Term Care Advocates: Pending Bush Medicare Cut Hurts State's Rural Seniors 2Health News:Minnesota, National Long Term Care Advocates: Pending Bush Medicare Cut Hurts State's Rural Seniors 3Health News:Minnesota, National Long Term Care Advocates: Pending Bush Medicare Cut Hurts State's Rural Seniors 4Health News:Governor Rendell Says PA ABC Will Help Low-Wage Small Businesses Pay for Employee Health Coverage 2Health News:Governor Rendell Says PA ABC Will Help Low-Wage Small Businesses Pay for Employee Health Coverage 3Health News:Governor Rendell Says PA ABC Will Help Low-Wage Small Businesses Pay for Employee Health Coverage 4Health News:Diabetes doubles liver cancer risk for patients with advanced hepatitis C 2Health News:Nuvo licenses topical pain product from Paladin 2Health News:Nuvo licenses topical pain product from Paladin 3
(Date:11/6/2009)...LAND, Calif., Nov. 6 Kaiser Founda...s (KFHP/H), and their subsidiaries reported today ...n for the quarter ended September 30, 2009, compar...ear. Operating income in the third quarter was $33...uarter of last year. Net non-operating income was ...
(Date:11/6/2009)...ROIT, Nov. 6 Caraco Phar...as launched ketorolac tromethamine ophthalmic solu...Food and Drug Administration (FDA) for Sun Pharma,...ric Acular® ophthalmic solution on the first ...ketorolac is therapeutically equivalent to Acular&...
(Date:11/6/2009)...NCETON, N.J., Nov. 6 D...a provider of advanced wound care products, announ...s before market on Monday, November 16, 2009. The ...to discuss the results at 11:00 am EST. Interested...(857) 350-1684 (international), with passcode 8141...
Breaking Medicine Technology:Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 2Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 3Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 4Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2AstraZeneca Submits New Drug Applications for ZACTIMA 28TM 29 in Second Line Advanced Non Small Cell Lung Cancer 53204 1AstraZeneca Submits New Drug Applications for ZACTIMA 28TM 29 in Second Line Advanced Non Small Cell Lung Cancer 53204 2AstraZeneca Submits New Drug Applications for ZACTIMA 28TM 29 in Second Line Advanced Non Small Cell Lung Cancer 53204 3AstraZeneca Submits New Drug Applications for ZACTIMA 28TM 29 in Second Line Advanced Non Small Cell Lung Cancer 53204 4Sunesis Receives Approval for Listing on The NASDAQ Capital Market 13280 1Sunesis Receives Approval for Listing on The NASDAQ Capital Market 13280 2Sunesis Receives Approval for Listing on The NASDAQ Capital Market 13280 3Lotus Pharmaceuticals Inc Announces Patent Pending Gliclazide Controlled Release Tablets 13278 1Lotus Pharmaceuticals Inc Announces Patent Pending Gliclazide Controlled Release Tablets 13278 2Lotus Pharmaceuticals Inc Announces Patent Pending Gliclazide Controlled Release Tablets 13278 3
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products: